Enfusion, Inc.
ENFN
ENFN was delisted on the 17th of April, 2025.
132 hedge funds and large institutions have $939M invested in Enfusion, Inc. in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 36 reducing their positions, and 10 closing their positions.
2,122% more call options, than puts
Call options by funds: $1.22M | Put options by funds: $55K
230% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 10
36% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 36
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
21% more funds holding
Funds holding: 109 → 132 (+23)
9% more capital invested
Capital invested by funds: $861M → $939M (+$77.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACL
Azora Capital LP
Miami,
Florida
|
+$9.39M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$5.46M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
+$4.04M |
| 4 |
ER
EVR Research
Richmond,
Virginia
|
+$3.87M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1WCM
12 West Capital Management
New York
|
-$18.1M |
| 2 |
NCM
Nellore Capital Management
Redwood City,
California
|
-$11.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.54M |
| 4 |
SGM
Scalar Gauge Management
Dallas,
Texas
|
-$4.14M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.35M |
ENFN Hedge Fund Activity: Q4 2024 in Review
132 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q4 2024, worth a combined $939M — up 9% from $861M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new ENFN positions and 10 closed out — a net gain of 23 holders — while 49 added to existing stakes and 36 trimmed.
The largest buyer was Azora Capital LP, adding an estimated $9.39M. The largest seller was 12 West Capital Management, exiting entirely with an estimated $18.1M sold.
- 132 institutional investors held Enfusion, Inc. (ENFN) as of Q4 2024, up from 109 in Q3 2024.
- Funds reported $939M of Enfusion, Inc. stock for Q4 2024, up 9% quarter-over-quarter.
- 33 funds opened new Enfusion, Inc. positions in Q4 2024 and 10 closed out, a net change of +23 holders.
- The largest Enfusion, Inc. buyer in Q4 2024 was Azora Capital LP, an estimated $9.39M added.
- The largest Enfusion, Inc. seller in Q4 2024 was 12 West Capital Management, an estimated $18.1M sold.
Based on aggregated 13F filings for Q4 2024.